Finished
Robotic Natural Orifice Specimen Extraction Surgery Versus Robotic Transabdominal Specimen Extraction Surgery for Early-Stage Rectal Cancer
NCT06405308 · Taiyuan Li · Updated 13 May 2024
- What is being tested
- R-NOSES group; R-TSES group
- For
- Rectal Cancer; Robotic Surgery; Natural Orifice Specimen Extraction Surgery
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 86 years. About 636 people. The full rules are on the registry page.
- Where
- China (8 sites)
- When
- Starts or started 1 Oct 2023, ends 15 Jan 2024. Registered 8 May 2024.
- Results
- None posted yet.
In the researchers' words
A retrospective cohort study, conducted nationwide（China） and across multiple centers, aimed to compare the surgical quality and short-term outcomes of R-NOSES （robotic natural orifice specimen extraction surgery）with R-TSES （robotic transabdominal specimen extraction surgery） for early-stage rectal cancer.
Sites
- The Second Xiangya Hospital of Central South UniversityChangsha, Hunan, China
- Cancer Institute and Hospital, Chinese Academy of Medical SciencesBeijing, China
- Three Gorges Hospital Affiliated to Chongqing UniversityChongqing, China
- Fujian Cancer HospitalFuzhou, China
- The Second Affiliated Hospital of Harbin Medical UniversityHarbin, China
- The First Affiliated Hospital of Nanchang UniversityNanchang, China
- Zhongshan Hospital, Fudan UniversityShanghai, China
- The First Affiliated Hospital of Zhengzhou UniversityZhengzhou, China